Eton Pharmaceuticals Inc stock is traded at $47.15, with a volume of 681,970. It is down -7.04% in the last 24 hours and down -15.23% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Previous Close:
$50.72
Open:
$51.15
24h Volume:
681,970
Relative Volume:
1.68
Market Cap:
$1.35B
Revenue:
$86.93M
Net Income/Loss:
-$1.48M
P/E Ratio:
-
EPS:
-$0.0709
Net Cash Flow:
$431.00K
1W Performance:
-12.15%
1M Performance:
-15.23%
6M Performance:
+55.20%
1Y Performance:
+144.94%
1-Day Range:
$47.03$51.97
1-Week Range:
$47.03$53.75
52-Week Range:
$14.27$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals IncSector
HealthcarePhone
(847) 787-7361Address
21925 W. FIELD PARKWAY, DEER PARK, IL, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS